MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$948,340
Net Income
-$842,910
Net Profit Margin
-88.88%
EPS
-$0.04
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenue
948,340
983,536
1,305,512*
756,217
Cost of revenue
864,774
698,049
1,143,889.5*
815,871
Gross profit (gain)
83,566
285,487
161,622.5*
-59,654
Selling expenses
113,764
95,598
128,058*
78,041
General and administrative expenses
1,376,974
1,226,272
1,243,605.5*
424,827
Research and development expenses
19,135
83,762
176,039*
40,321
Credit losses
5,538
-2,881
-36,986.5*
25,302
Total operating expenses
1,515,411
1,402,751
1,510,716*
568,491
Loss from operations
-1,431,845
-1,117,264
-1,349,093.5*
-628,145
Research and development subsidy
-
-
155,736.5*
415
Interest income
81
147
1,121*
294
Interest expense
26,359
26,031
29,899*
24,046
Net other (expense) income
-26,278
-25,884
126,958.5*
-23,337
Loss before income taxes
-1,458,123
-1,143,148
-1,222,135
-651,482
Net loss
-1,458,123
-1,143,148
-1,222,135
-651,482
Other comprehensive income - foreign currency translation adjustment
615,213
433,586
177,890
57,335
Comprehensive loss
-842,910
-709,562
-1,044,245
-594,147
Basic EPS
-0.04
-0.04
-0.154
-0.17
Diluted EPS
-0.04
-0.04
-0.185*
-0.17
Basic Average Shares
40,522,002
25,602,002
6,767,710
3,874,085
Diluted Average Shares
40,522,002
25,602,002
-
-
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive loss
-$842,910
(-65.89%↓ Y/Y)
Other comprehensive
income - foreign...
$615,213
(2936.14%↑ Y/Y)
Net loss
-$1,458,123
(-175.97%↓ Y/Y)
Loss before income
taxes
-$1,458,123
(-175.97%↓ Y/Y)
Revenue
$948,340
Loss from operations
-$1,431,845
Net other (expense)
income
-$26,278
Gross profit (gain)
$83,566
Interest income
$81
Cost of revenue
$864,774
Total operating
expenses
$1,515,411
Interest expense
$26,359
General and
administrative expenses
$1,376,974
Selling expenses
$113,764
Research and development
expenses
$19,135
Credit losses
$5,538
Buy us a coffee
CHINA PHARMA HOLDINGS, INC. (CPHI)
CHINA PHARMA HOLDINGS, INC. (CPHI)